ARCHIVES

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

This article is from The Cancer Letter archive.

Vol. 11 No. 03 | January 18, 1985

Download PDF Visit The Full Archive

Related Articles

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

60 Minutes To Air Segment On The “Deception at Duke”

February 10, 2012

FDA, NCI Near Agreement On Handling INDs

January 28, 1977

USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening

September 28, 2012